Akèy › Maladi Greff-versus-host › Massachusetts › Boston
Etid klinik pou Maladi Greff-versus-host nan Boston, MA
10 etid pou Maladi Greff-versus-host ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
Ap rekrite
- Massachusetts General Hospital, Boston
Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD
Ap rekriteFaz 1
- Dana-Farber Cancer Institute, Boston
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Ap rekriteFaz 2
- Massachusetts General Hospital, Boston
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
Ap rekriteFaz 3
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
Ap rekriteFaz 2
- Boston Children's Hospital, Boston
Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial
Ap rekrite
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
Ap rekriteFaz 2
- Dana-Farber Cancer Institute, Boston
Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
Ap rekriteEtid obsèvasyon
- Dana Farber, Boston
IS-free Treg HaploHCT
Ap rekriteFaz 1
- Dana Farber Cancer Institute, Boston
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
Ap rekriteFaz 1
- Dana-Farber Cancer Institute, Boston
Etid Maladi Greff-versus-host nan lòt vil
- New York City, NY7 etid
- Columbus, OH6 etid
- Baldwin Park, CA5 etid
- Atlanta, GA5 etid
- Washington, DC5 etid
- Pittsburgh, PA4 etid
- Detroit, MI4 etid
- Portland, OR4 etid
- St. Louis, MO4 etid
- Tampa, FL4 etid
- Seattle, WA4 etid
- Miami, FL4 etid
Lòt etid nan Boston
- Kansè nan tete112 etid
- Kansè Poumon ki pa ti selil90 etid
- Kansè (tout kalite)85 etid
- Kansè Metastatik63 etid
- Kansè kolorektal63 etid
- Kansè poumon62 etid
- Kansè ovè61 etid
- Kansè pwostat59 etid
- Depresyon52 etid
- Kansè Endomèt50 etid
- Ensifizyans kadyak44 etid
- Leksemi mieloïd egi44 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.